Register to receive a free European Market Report Suite for Orthopedic Large Joint Devices report synopsis and brochure

According to a new series of reports on the European market for orthopedic large joint devices by iData Research, knee replacement device unit sales in Europe has picked up due to reduced prices allowing for more elective procedures. The long-term growth of the market will be strongly driven by the increasing demand for revision surgeries. Revision knee replacement is the fastest growing segment of the combined knee reconstruction device market. However, as with most of the orthopedic market, prices are declining in Europe and the revision knee market’s average selling price (ASP) will decline over the next several years.

“Despite lower ASPs, unit sales growth can be attributed to the increased demand for revision surgery due to the rise in the number of younger knee implant patients,” explains Dr. Kamran Zamanian, CEO of iData. “Since the lifespan of knee implants is normally 15 years, the implants of younger patients will not last to the end of their life and will require revision.”

The largest segment of the combined knee replacement device market is the market for total knee replacements. As primary knee implants become increasingly affordable due to pricing pressure imposed by governmental bodies across Europe, more people will have their knees replaced sooner. This will result in a slight recovery in the growth of the market as the number of people still waiting for this elective surgery will decrease.

Germany accounts for the largest number of total knee replacement unit sales. France and the U.K. have the second and third highest unit sales respectively. Though the potential market in Italy is similar to that of France and the U.K., its smaller economy hampers the growth of its unit sales. Italy’s economic recovery is allowing more knee replacements to be performed. All countries are experiencing an ASP decline. Portugal has been experiencing the largest decline in the prices of primary knee replacements. These countries seek to reduce implant prices to help manage government spending, rather than only limiting the number of procedures.

Zimmer Biomet is the leading competitor in the European knee replacement market. Zimmer Biomet sells total knee, partial and revision products under a variety of brand names. Their products include the Vanguard® Complete Knee, Oxford® Partial Knee and Vanguard® 360 Revision Knee as well as the E1 Antioxidant Infused bearing. DePuy Synthes is the second leading competitor in the market with a strong presence in the orthopedic market, particularly within the orthopedic trauma device market. This provides DePuy Synthes a strong brand and the ability to familiarize in-training surgeons with their products. Additional competitors in the European knee replacement market include Stryker, Smith & Nephew, Aesculap, Tornier, Amplitude, Exactech, Mathys, Link, DJO Global, Medacta, Lima, SAMO and Gruppo Bioimpianti among others.

For Further Information
More on the orthopedic large joint market in Europe can be found in a series of reports published by iData Research entitled the European Market Report Suite for Orthopedic Large Joint Devices.